Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	28.24	27.90	21.76
Graham Fair Price	-21.60	2095.98	2673.60
PEG	89.64	-0.32	-3.07
Price/Book	15.47	0.66	0.57
Price/Cash Flow	-34.04	7.61	-11.54
Prices/Earnings	79.15	11.79	6.58
Price/Sales	15.22	1.24	1.08
Price/FCF	-34.04	7.61	-11.54
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-3.42	0.13	0.13
Operating Margin	-36.62	0.04	0.06
ROA	-35.80	< 0.005	< 0.005
ROE	0.02	0.01	-35.55
ROIC	0.01	< 0.005	-33.49
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.04	< 0.005	-719.00
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	-0.04	-0.36	-771.33
EPS QOQ	-0.02	-0.37	-1628.82
FCF QOQ	-1.50	2.77	84.45
Revenue QOQ	-0.02	0.02	-20.63
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	106.82	106.13	-0.64
Days Sales Outstanding (DSO)	67.44	62.08	-7.96
Inventory Turnover	0.84	0.85	0.65
Debt/Capitalization	0.44	0.43	-3.01
Quick Ratio	0.72	0.71	-1.41
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	3824.41	3734.49	-2.35
Cash	222.39	368.40	65.65
Capex	-126.00	-150.32	-19.30
Free Cash Flow	-189.63	324.14	70.93
Revenue	2027.04	1983.67	-2.14
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.66	1.62	-2.31
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.24	13.78	12.57
Naive Interpretation	Member

06 - Financial Health · Weak

Rating